StonvexLoading…
StonvexStonvexStonvexCore line items from DUOT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $27.02M | $7.28M | $7.47M | $15.01M |
Operating Income | $-9.76M | $-10.98M | $-11.45M | $-6.87M |
Net Income | $-9.84M | $-10.76M | $-11.24M | $-6.86M |
EPS (Diluted) | $-0.64 | $-1.39 | $-1.56 | $-1.11 |
Total Assets | $63.41M | $34.96M | $12.84M | $13.09M |
Total Liabilities | $14.86M | $32.70M | $7.48M | $9.04M |
Cash & Equivalents | $15.47M | $6.27M | $2.44M | $1.12M |
Free Cash Flow OCF − CapEx | $-37.41M | $-5.32M | $-9.24M | $-8.22M |
Shares Outstanding | 20.45M | 8.92M | 7.31M | 7.16M |